Independently of its binding with FLNa, PrPC affects the cytoskeletal organization by modulating the Akt-hsp27-F-actin axis, thus enhancing cancer cell migration in M2 melanoma cells which lack FLNa expression [41]. This evidence concerns the gene AKT1 and melanoma.